The reigning Vancouver and Montreal Half Marathon champion, Mohamed Aagab of Campbellton, N.B., has acquired a three-year suspension for an anti-doping rule violation by the Canadian Centre for Ethics in Sport (CCES).
Aagab supplied a urine pattern after successful the 2023 BMO Vancouver Half Marathon on Might 7, which revealed the presence of recombinant erythropoietin (rEPO), a prohibited peptide hormone used to enhance efficiency by rising the blood’s capability to hold oxygen.
Aagab was born in Morocco however has lived in Campbellton, N.B., since 2018. He gained the Quebec Metropolis Marathon in 2018 and the 2023 21K de Montréal, in addition to the 2023 BMO Vancouver Half Marathon.
In line with CCES, on Oct. 3, Aagab signed an Early Admission and Acceptance Settlement, admitting to the violation and accepting the interval of ineligibility and all different penalties. In consequence, the in any other case relevant four-year interval of ineligibility was decreased by one yr, in accordance with the Canadian Anti-Doping Program (CADP). Aagab’s three-year suspension, efficient Sept. 12, 2023, terminates on Sept. 11, 2026.
Mohamed Aagab wins 2018 SSQ Quebec Metropolis Marathon
Aagab competed twice after his optimistic check on Might 7, ending fifteenth total on the 2023 Ottawa Marathon in 2:18:34, ending one spot behind prime Canadian Lee Wesselius, who was 14th. He additionally ran in a 5,000m on the Hub Metropolis Basic in Moncton, N.B. on June 10, the place he completed third, in 15:27. Each outcomes shall be disqualified, alongside along with his Vancouver Half Marathon win.
In the course of the sanction interval, Aagab is ineligible to take part in any capability with any sport signatory to the CADP, together with coaching with teammates.
That is the primary distance working anti-doping in Canada case since David Freake of St. John’s, N.L. was given a four-year doping ban when he examined optimistic for EPO and several other different banned substances after the 2019 Ottawa Marathon.